Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Takeda to Open New Plant in Germany | Contract Pharma

What are you searching for?

Sign in
Breaking News

Takeda to Open New Plant in Germany

Will manufacture the company's dengue vaccine candidate TAK-003

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Takeda will open a new plant in Singen, Germany that will manufacture the company’s dengue vaccine candidate, TAK-003. Phase III results show the vaccine is effective against the mosquito-borne virus. 

The company began construction in 2016 and invested approximately $140 million to build the facility. It will employ as many as 200 people once operational. The plant is currently ready for packaging production and production of the vaccine, once approved.
 
In a placebo-controlled study that included more than 20,000 children, the vaccine was approximately 80% effective in protecting against dengue infection. The vaccine was generally well tolerated with no significant safety risks observed to date. According to the company Dengue causes about 390 million infections and 20,000 deaths a year.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics